Page last updated: 2024-10-29

avapro and Lupus Erythematosus, Systemic

avapro has been researched along with Lupus Erythematosus, Systemic in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research Excerpts

ExcerptRelevanceReference
"A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment."5.39Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013)
"A substantial number of patients with lupus nephritis (LN) are refractory to conventional glucocorticoid (GC) treatment."1.39Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. ( Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurasawa, T1
Nagasawa, H1
Nishi, E1
Takei, H1
Okuyama, A1
Kondo, T1
Nishimura, K1
Sakai, R1
Shibata, A1
Chino, K1
Ogawa, H1
Ito, T1
Amano, K1
Kato, H1
Sahin, G1
Korkmaz, C1
Işiksoy, S1
Yalçin, AU1

Other Studies

2 other studies available for avapro and Lupus Erythematosus, Systemic

ArticleYear
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10

    Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therap

2013
Autoimmune hypothyroidism and lupus-like syndrome.
    Rheumatology international, 2010, Volume: 30, Issue:4

    Topics: Adult; Arthritis; Azathioprine; Biphenyl Compounds; Complement C3; Complement C4; Complement System

2010